ARTICLE | Company News
Focal Inc. deal
June 5, 2000 7:00 AM UTC
The FDA granted marketing approval for FocalSeal-L to seal air leaks during lung surgery. Based on the recommendations of an FDA advisory panel earlier this month, FOCL will conduct annual follow-up monitoring of the 180 patients in its FocalSeal-L pivotal trial for five years. ...